Influenza Virus

Influenza Virus

The influenza virus is a member of the Orthomyxoviridae family of segmented, single-stranded, negatively charged RNA viruses. Three different influenza virus types—A, B, and C—are included in this group. The type A viruses infect both domesticated and wild birds, horses, swine, other mammals, and humans, while the type B and C viruses only affect humans.In the United States, seasonal epidemics of disease are brought on by human influenza A and B viruses almost every winter. An influenza pandemic can be brought on by the spread of a brand-new, radically different influenza virus. Infections with influenza type C are thought to only cause a mild respiratory illness and not epidemics. Each virus subtype has undergone mutation, resulting in a variety of strains with various levels of pathogenicity; some are pathogenic to one species but not to others, and some are pathogenic to several.

Influenza Virus related products

Structure Cat No. Product Name CAS No. Product Description
V53064 Oseltamivir (oseltamivir; GS 4104) 196618-13-0 Oseltamivir (GS 4104) is an orally bioactive influenza virus neuraminidase inhibitor (NAI).
V54327 Oseltamivir acid-d3 (GS 4071-d3; Ro 64-0802-d3; Oseltamivir carboxylate-d3) 1242184-43-5 Oseltamivir acid-d3 is a deuterated form of Oseltamivir acid.
V53056 Oseltamivir-acetate 1191921-01-3 Oseltamivir-acetate is an impurity of Oseltamivir.
V80108 Oseltamivir-d3 phosphate (GS 4104-d3 (phosphate)) Oseltamivir-d3 (phosphate)e is the deuterated form of Oseltamivir phosphate.
V80113 Oseltamivir-d3-1 (oseltamivir-d3-1) Oseltamivir-d3-1 is the deuterium labelled form of Oseltamivir.
V52657 Oseltamivir-d5 1093851-63-8 Oseltamivir-d5 is the deuterium labelled form of Oseltamivir.
V9167 Peramivir (BCX-1812, RWJ-270201, S-021812) 330600-85-6 Peramivir (formerly RWJ270201;BCX1812; S021812; Rapivab; Rapiacta; Peramiflu)is an antiviral agent acting as a neuraminidase inhibitor and has been approved for treating influenza.
V2442 Peramivir Trihydrate (RWJ-270201; BCX-1812) 1041434-82-5 Peramivir Trihydrate (also known as BCX-1812, RWJ-270201, S-021812; trade name Rapivab)is a trihydrate form of the antiviral agent peramivirwhich is a transition-state analogue and a specific influenza viral neuraminidase inhibitor approved for the treatment of influenza.
V54326 Pinellic acid 97134-11-7 Pinellic acid is a naturally occurring compound extracted from the medicinal plant Pinelliae tuber.
V54334 RdRP-IN-3 2641299-75-2 RdRP-IN-3 becomes a promising anti-influenza candidate molecule by inhibiting the activity of RNA-dependent RNA polymerase (RdRP).
V54338 RdRP-IN-5 2915761-74-7 RdRP-IN-5 (compound 20) is a potent inhibitor of influenza virus RNA-dependent RNA polymerase (RdRP).
V33184 Rimantadine 13392-28-4 Rimantadine(Flumadine) is an oral anti-influenza virus drug useful in the prophylaxis and treatment of influenza A virus infections.
V52552 Rimantadine-d4 hydrochloride 350818-67-6 Rimantadine-d4 (HCl) is the deuterium labelled form of Rimantadine.
V30529 S119-8 443639-96-1 S119-8 is a broad spectrum inhibitor of influenza A and B viruses.
V35061 Soyasaponin II 55319-36-3 Soyasaponin II is a saponin with antiviral effect.
V7654 T-1105 55321-99-8 T-1105 (T1105), ananalog of T-705 (favipiravir), is a novel and potent broad-spectrum antiviral inhibitor thatinhibits the polymerases of RNA viruses after being converted to the actiive form: ribonucleoside triphosphate (RTP) metabolite.
V53234 TAT-HA2 Fusion Peptide 923954-79-4 TAT-HA2 Fusion Peptide is a bioactive peptide-based delivery agent that combines a pH-sensitive HA2 fusion peptide from Influenza with the cell-penetrable peptide TAT from HIV.
V29874 Thymalfasin 62304-98-7 Thymalfasin (thymosin-alpha 1) is an Immune-modulatory compound that enhances Thl immune responses.
V79340 trans-RdRP-IN-5 trans-RdRP-IN-5 (compound 18) is a potent inhibitor of influenza virus RNA-dependent RNA polymerase (RdRP).
V34784 Trifluoperazine dimaleate 605-75-4 Trifluoperazine dimaleate is an antipsychotic that acts by blocking central dopamine receptors.
Contact Us Back to top